Tyme To Present Prostate Cancer Data From Its Ongoing Phase II Trial For SM-88 At Post author:Sam Post published:August 28, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Alzheon To Present Novel Molecular Mechanism Of Action And Long Term Clinical Efficacy Data For Lead Candidate ALZ-801 At June 21, 2017 Mysterious Moderna Hints at Its IPO Timeline November 2, 2017 3 Biotechs Breathing Down Bristol-Myers Squibb's Neck February 2, 2017
Alzheon To Present Novel Molecular Mechanism Of Action And Long Term Clinical Efficacy Data For Lead Candidate ALZ-801 At June 21, 2017